Synergistic effects between aminoethyl-chitosans and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA)

Bioorg Med Chem Lett. 2010 Feb 1;20(3):975-8. doi: 10.1016/j.bmcl.2009.12.049. Epub 2009 Dec 21.

Abstract

Two kinds of aminoethyl-chitosans (AEC), AEC90 and AEC50, which had degrees of deacetylation of 90% and 50%, respectively, were prepared and their synergistic effects in combination with beta-lactams including ampicillin, penicillin, and oxacillin against two standard methicillin-resistant Staphylococcus aureus (MRSA) strains and twelve clinical isolated MRSA strains were investigated. When AECs and beta-lactams were combined, synergistic effects were observed with fractional inhibitory concentration (FIC) indices of 0.252-0.508, and the MICs of beta-lactams in the presence of AECs were dramatically reduced.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chitosan / administration & dosage*
  • Chitosan / chemistry
  • Drug Synergism
  • Drug Therapy, Combination
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / physiology
  • Microbial Sensitivity Tests / methods
  • beta-Lactams / administration & dosage*
  • beta-Lactams / chemistry

Substances

  • beta-Lactams
  • Chitosan